Kingsview Wealth Management, LLC Abb Vie Inc. Call Options Transaction History

Kingsview Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Dec 03, 2021	SELL	$106.4 - $120.78 $42,560 - $48,312	-400 Reduced 57.14%	300 $0
Q3 2019 Jan 29, 2020	SELL	$62.98 - $75.72 $25,192 - $30,288	-400 Reduced 36.36%	700 $0
Q2 2019 Jan 29, 2020	BUY	$65.7 - $83.98 $59,130 - $75,582	900 Added 450.0%	1,100 $1,000
Q1 2018 Jan 29, 2020	SELL	$92.01 - $123.21 $9,201 - $12,321	-100 Reduced 33.33%	200 $0
Q3 2017 Jan 29, 2020	BUY	$69.85 - $89.22 $20,955 - $26,766	300	300 $1,000

3,846

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kingsview Wealth Management, LLC with notifications on news.